Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.0279 | 0.0204 | 0.3201 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0204 | 0.0118 | 0.0566 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0227 | 0.0144 | 1 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.3334 | 0.3742 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0399 | 0.0343 | 1 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.0279 | 0.0204 | 0.5313 |
Brugia malayi | ERG2 and Sigma1 receptor like protein | 0.0278 | 0.0203 | 0.5273 |
Brugia malayi | Matrixin family protein | 0.018 | 0.0089 | 0.2321 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.3334 | 0.3742 | 1 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.8737 | 1 | 0.5 |
Brugia malayi | Matrixin family protein | 0.018 | 0.0089 | 0.2321 |
Loa Loa (eye worm) | matrix metalloproteinase | 0.018 | 0.0089 | 0.0344 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0089 | 0.0344 |
Brugia malayi | Hemopexin family protein | 0.0255 | 0.0176 | 0.4584 |
Trypanosoma brucei | Peptide deformylase 2 | 0.3334 | 0.3742 | 1 |
Schistosoma mansoni | matrix metallopeptidase-9 (M10 family) | 0.0139 | 0.0042 | 0.0743 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.3334 | 0.3742 | 1 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0204 | 0.0118 | 0.3057 |
Loa Loa (eye worm) | matrixin family protein | 0.0435 | 0.0385 | 0.2661 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0204 | 0.0118 | 0.0011 |
Echinococcus granulosus | adam 17 protease | 0.065 | 0.0634 | 0.9933 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0089 | 0.0344 |
Schistosoma mansoni | hypothetical protein | 0.0255 | 0.0176 | 0.3116 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0128 | 0.0029 | 0.0517 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0204 | 0.0118 | 0.3057 |
Trichomonas vaginalis | Sialidase-1 precursor, putative | 0.0227 | 0.0144 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0399 | 0.0343 | 0.2334 |
Mycobacterium tuberculosis | Possible exported protein | 0.0489 | 0.0448 | 0.0317 |
Echinococcus multilocularis | adam 17 protease | 0.0591 | 0.0566 | 0.8863 |
Brugia malayi | Matrixin family protein | 0.018 | 0.0089 | 0.2321 |
Plasmodium falciparum | peptide deformylase | 0.8737 | 1 | 1 |
Trypanosoma brucei | C-8 sterol isomerase, putative | 0.0278 | 0.0203 | 0.0246 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0204 | 0.0118 | 0.0011 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0591 | 0.0566 | 1 |
Onchocerca volvulus | 0.0255 | 0.0176 | 0.3431 | |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0654 | 0.0638 | 1 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.3334 | 0.3742 | 1 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.0371 | 0.0311 | 0.4867 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0204 | 0.0118 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0204 | 0.0118 | 0.0566 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0654 | 0.0638 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0399 | 0.0343 | 1 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.8737 | 1 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0204 | 0.0118 | 0.1842 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0204 | 0.0118 | 0.1842 |
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.0279 | 0.0204 | 0.3201 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0204 | 0.0118 | 0.0011 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.8737 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.8737 | 1 | 1 |
Treponema pallidum | polypeptide deformylase (def) | 0.8737 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0089 | 0.0344 |
Loa Loa (eye worm) | hypothetical protein | 0.1242 | 0.132 | 1 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.0371 | 0.0311 | 0.4867 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0204 | 0.0118 | 0.2078 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.3334 | 0.3742 | 1 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.3334 | 0.3742 | 1 |
Brugia malayi | Matrixin family protein | 0.018 | 0.0089 | 0.2321 |
Trypanosoma cruzi | C-8 sterol isomerase, putative | 0.0278 | 0.0203 | 0.0246 |
Loa Loa (eye worm) | hypothetical protein | 0.0219 | 0.0135 | 0.07 |
Leishmania major | C-8 sterol isomerase-like protein | 0.0278 | 0.0203 | 0.0235 |
Mycobacterium ulcerans | peptide deformylase | 0.8737 | 1 | 1 |
Plasmodium vivax | peptide deformylase, putative | 0.8737 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0278 | 0.0203 | 0.1235 |
Brugia malayi | Matrixin family protein | 0.0435 | 0.0385 | 1 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0219 | 0.0135 | 0.3501 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.018 | 0.0089 | 0.1578 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.0279 | 0.0204 | 0.3612 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 37 % | Inhibition of the leukotriene D4 (LTD4)-induced contraction of guinea pig tracheal spirals at 10 microM concentration | ChEMBL. | 2704027 |
Inhibition (functional) | = 90 % | Percent inhibition of the leukotriene D4 (LTD4)-induced contraction of guinea pig tracheal spirals at 50 microM concentration | ChEMBL. | 2704027 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.